Abstract
The incidence of Alzheimer’s disease is predicted to rise as life expectation grows across populations. The cause of the disease is unknown, and very likely multifactorial. Pharmacological attempts have been unsuccessful, and a pharmacological magic bullet is unlikely to be found. This raises the question how lifestyles, especially our modern way of life, contributes to the risk, and how this might be prevented through lifestyle measures. We have conducted a series of systematic reviews of the literature and describe here important lifestyle elements that have some support in favor of them. These are: avoiding toxins, especially heavy metals; a diet emphasizing a good balance of essential fatty acids, a reduction of intake of easily degradable carbohydrates and diet rich in antioxidants; physical exercise and a culture of consciousness, including healthy social relationships. The challenge of the future will be to find a way of individual lifestyle counseling that respects the eminently individual way how lifestyles are realized as genuine expressions of individual choices.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
This is confirmed by our own meta-analysis that included studies up to 2011, as yet unpublished.
References
Angermayr, L., Melchart, D., et al. (2010). The diagnosis of mild cognitive impariment due to Alzheimer’s disease: recommendations from the National Institute of Aging and Alzheimer’s Association workgroup. Annals of Behavioral Medicine, 40, 49–64.
Annweiler, C., Allali, G., et al. (2009). Vitamin D and cognitive performance in adults: a systematic review. European Journal of Neurology, 16(10), 1083–1089.
Anstey, K. J., Cherbuin, N., et al. (2011). Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obesity Reviews, 12(5), e426–e437.
Appel, L. J., Clark, J. M., et al. (2011). Comparative effectiveness of weight-loss interventions in clinical practice. New England Journal of Medicine, 365, 1959–1968.
Ascherio, A., & Willett, W. (1997). Health effects of Trans fatty acids. The American Journal of Clinical Nutrition, 66(4), 1006S–1010S.
Barabasi, A. L., Gulbahce, N., et al. (2011). Network medicine: a network-based approach to human disease. Nature Reviews Genetics, 12, 56–68.
Bartus, R. T., Dean, R. L, I. I. I., et al. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408–417.
Bauer, J. (2002). Psychobiologie der Alzheimer-Krankheit: Wirklichkeitskonstruktion und Beziehungsgestaltung. Integrierte Medizin: Modell und klinische Praxis. Uexküll, T. v., Geigges, W., & Plassmann, R. Stuttgart, Schattauer, pp. 157–175.
Bauer, J., Qualmann, J. et al. (1998). Lebenslaufuntersuchungen bei Alzheimer-Patienten: Qualitative Inhaltsanalyse pämorbider Entwicklungsprozesse. Psychosoziale Gerontologie: Band 2: Intervention. Kruse, A. Göttingen, Hogrefe, pp. 251–274.
Braak, H., & Del Tredici, K. (2011). The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathologica, 121(2), 171–181.
Braak, H., Thal, D. R., et al. (2011). Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. Journal of Neuropathology & Experimental Neurology, 70(11), 960–969. doi:910.1097/NEN.1090b1013e318232a318379.
Bremner, J. D., Vythilingam, M., et al. (2004). Effects of glucocorticoids on declarative memory function in major depression. Biological Psychiatry, 55, 811–815.
Clarke, R., Smith, A. D., et al. (1998). Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Archives of Neurology, 55(11), 1449–1455.
Cockerham, W. (2007). New directions in health lifestyle research. International Journal of Public Health, 52(6), 327–328.
Cohen, S. (2004). Social relationships and health. American Psychologist, 59(8), 676–684.
Cole, G. M., Ma, Q.-L., et al. (2009). Omega-3 fatty acids and dementia. Prostaglandins Leukotrienes and Essential Fatty Acids, 81, 213–221.
Coley, N., Andrieu, S., et al. (2008). Dementia prevention: methodological explanations for inconsistent results. Epidemiologic Reviews, 30, 35–66.
Contestabile, A. (2011). The history of the cholinergic hypothesis. Behavioural Brain Research, 221, 334–340.
Dangour, A., Whitehouse, P., et al. (2010). B-vitamins and fatty acids in the prevention and treatment of Alzheimer’s disease and dementia: a systematic review. Journal of Alzheimer’s Disease, 22, 205–224.
Daviglus, M. L., Plassman, B. L., et al. (2011). Risk factors and preventive interventions for Alzheimer disease: state of the science. Archives of Neurology, 9, 9.
de la Monte, S., & Wands, J. R. (2005). Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer’s disease. Journal of Alzheimer’s Disease, 7, 45–61.
de la Monte, S., & Wands, J. R. (2008). Alzheimer’s disease is type 3 diabetes—evidence reviewed. Journal of Diabetes Science and Technology, 2, 1101–1113.
De la Torre, J. C. (2011). Thre postulates to help identify the cause of Alzheimer’s disease. Journal of Alzheimers Disease, 24, 657–668.
de Lorgeril, M., Salen, P., et al. (2010). Cholesterol lowering, cardiovascular diseases, and the Rusvastatin-JUPITER controversy: a critical reappraisal. Archives of Internal Medicine, 170, 1032–1036.
del Sol, A., Balling, R., et al. (2010). Diseases as network perturbations. Current Opinion in Biotechnology., 21(4), 566–571.
den Heijer, T., Vermeer, S., et al. (2003). Homocysteine and brainatrophy on MRI of non-demented elderly. Brain, 126, 170–175.
Devore, E., Grodstein, F., et al. (2010). Dietary antioxidants and long-term risk of dementia. Archives of Neurology, 67(7), 819–825.
Dragicevic, N., Smith, A., et al. (2011). Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer’s amyloid-induced mitochondrial dysfunction. Journal of Alzheimers Disease, 26, 507–521.
Dubois, R. N., Abramson, S. B., et al. (1998). Cyclooxygenase in biology and disease. FASEB Journal, 12(12), 1063–1073.
Ebrahim, S., Taylor, F., et al. (2011). Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database of Systematic Reviews, 19(1), CD001561.
Emken, E. (1984). Nutrition and biochemistry of Trans and positional fatty acid isomers in hydrogenated oils. Annual review of nutrition, 339, 339–376.
Farrer, L. A., Cupples, L. A., et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA Journal of the American Medical Association, 278, 1349–1356.
Feart, C., Samieri, C., et al. (2009). Adherence to a mediterranean diet, cognitive decline, and risk of dementia. JAMA, 302(6), 638–648.
Fjorback, L. O., Arendt, M., et al. (2011). Mindfulness-based stress reduction and mindfulness based cognitive therapy—A systematic review of randomized controlled trials. Acta Psychiatrica Scandinavica, 124(2), 102–119.
Fjorback, L. O., & Walach, H. (2012). Meditation based therapies—A systematic review and some critical observations. Religions, 3, 1–18.
Flaten, T. P. (2001). Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Research Bulletin, 55(2), 187–196.
Fontana, L., & Klein, S. (2007). Aging, adiposity, and calory restriction. Journal of the American Medical Association, 297, 986–994.
Fotuhi, M., Mohassel, P., et al. (2009). Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nature Clinical Practice Neurology, 5(3), 140–152.
Frederickson, C., Suh, S., et al. (2000). Importance of zinc in the central nervous system: the zinc-containing neuron. Journal of Nutrition, 130(5), 1471S–1483S.
Giddens, A. (1991). Modernity and self-identity: self one society in the late modern age. Oxford: Polity.
Graff-Radford, N. R. (2011). Can aerobic exercise protect against dementia? Alzheimer’s Research Therapy, 3(1), 6.
Graves, A., Rajaram, L., et al. (1999). Cognitive decline and Japanese culture in a cohort of older Japanese Americans in King County, WA: the Kame Project. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 54(3), S154–S161.
Grosman, M., & Picot, A. (2009). Facteurs environnementaux impliqués dans la maladie d’Alzheimer. Le mercure dentaire, probable déterminant majeur. Médecine et Longevité, (in print).
Grossman, P., Schmidt, S., et al. (2004). Mindfulness based stress reduction and health: a meta-analysis. Journal of Psychosomatic Research, 37, 35–43.
Grothe, M., Zaborsky, L., et al. (2010). Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer’s disease. Cerebral Cortex, 20(7), 1685–1695.
Gusnard, D. A., & Raichle, M. E. (2001). Searching for a baseline: functional imaging and the resting human brain. Nature Reviews Neuroscience, 2, 685–694.
Hains, A. V., & Arnsten, A. F. T. (2008). Molecular mechanisms of stress-induced prefrontal cortical impairment: Implications for mental illness. Learning and Memory, 15, 551–564.
Håkansson, K., Rovio, S., et al. (2009). Association between mid-life marital status and cognitive function in later life: population based cohort study. BMJ British Medical Journal, 339, b2462.
Hamer, M., & Chida, Y. (2009). Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychological Medicine, 39(01), 3–11.
Hasselmo, M. E., & McGuaghy, J. (2004). High acetylcholine levels set circuit dynamics for attention and encoding and low acetylcholine levels set dynamics for consolidation. Progress in Brain Research, 145, 207–230.
Hauswirth, C. B., Scheeder, M. R. L., et al. (2004). High omega-3 fatty acid content in alpine cheese: the basis for an Alpine paradox. Circulation, 109, 103–107.
Hendrie, H. C., Ogunniyi, A., et al. (2001). Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. Journal of the American Medical Association, 285(6), 739–747.
Hofman, A., de Jong, P. T. V. M., et al. (2006). Epidemiology of neurological diseases in elderly people: what did we learn from the Rotterdam Study? The Lancet Neurology, 5(6), 545–550.
Hölzel, B. K., Carmody, J., et al. (2009). Stress reduction correlates with structural changes in the amygdala. Social Cognitive and Affective Neuroscience, 5(1), 11–17. doi:10/1093/scan/nsp034.
Hölzel, B. K., Ott, U., et al. (2007a). Investigation of mindfulness meditation practicioners with voxel-based morphometry. Social Cognitive and Affective Neuroscience, 3(1), 55–61.
Hölzel, B. K., Ott, U., et al. (2007b). Differential engagement of anterior cingulate and adjacent medial frontal cortex in adept meditators and non-meditators. Neuroscience Letters, 421, 16–21.
Howard, R., McShane, R., et al. (2012). Donezepil and memantine for moderate-to-severe Alzheimer’s disease. New England Journal of Medicine, 366, 893–903.
Hsu, C.-C., Wahlqvist, M. L., et al. (2011). Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metforming. Journal of Alzheimers Disease, 24, 485–493.
International, A. S. D. (2010). World Alzheimer Report 2010.
Isaac, M., Quinn, R. et al. (2008). Vitamin E for Alzheimer’s disease and mild cognitive impairment. Cochrane Database of Systematic Reviews (Online) (3), CD002854.
Issa, A. M., Mojica, W. A., et al. (2006). The efficacy of omega-3 fatty acids on cognitive function in aging and dementia: a systematic review. Dementia and Geriatric Cognitive Disorders, 21(2), 88–96.
Janus, C., Pearson, J., et al. (2000). A-beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer’s disease. Nature, 408(6815), 979–982.
Johansson, L., Guo, X., et al. (2010). Midlife psychological stress and risk of dementia: a 35 year longitudinal populations study. Brain, 133, 2217–2224.
Karp, A., Kåreholt, I., et al. (2004). Relation of education and occupation-based socioeconomic status to incident Alzheimer’s disease. American Journal of Epidemiology, 159(2), 175–183.
Keng, S.-L., Smoski, M. J., et al. (2011). Effects of mindfulness on psychological health: a review of empirical studies. Clinical Psychology Review, 31, 1041–1056.
Kudielka, B. M., & Kirschbaum, C. (2007). Biological bases of the stress response. In M. Al’ Absi (Ed.), Stress and addiction: biological and psychological mechanisms (pp. 3–19). Amsterdam: Elsevier.
Lazar, S., Bush, G., et al. (2000). Functional brain mapping of the relaxation response and meditation. Neuro Report, 11, 1581–1585.
Lerman, R. H. (2006). Essential fatty acids. Integrative Medicine, 5(3), 34–44.
Levenson, C. W., & Axelrad, D. M. (2006). Too much of a good thing? Update on fish consumption and mercury exposure. Nutrition Reviews, 63, 139–145.
Levitan, E. B., Wolk, A., et al. (2009). Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middle-aged and elderly men. European Heart Journal, 30(12), 1495–1500.
Lewis, R. A., Austen, K. F., et al. (1990). Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. New England Journal of Medicine, 323(10), 645–655.
Lim, W. S., Gammack, J. K., et al. (2006). Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst Rev, 25(1), CD005379.
Littarru, G. P., & Langsjoen, P. (2007). Coenzyme Q10 and statins: biochemical and clinical implications. Mitochondrion, 7(1), S168–S174.
Loef, M., Mendoza, L. F., et al. (2011a). Lead (Pb) and the risk of Alzheimer’s disease or cognitive decline: a systematic review. Toxin Reviews, 30(4), 103–114.
Loef, M., Schrauzer, G. N., et al. (2011b). Selenium and Alzheimer’s disease: a systematic review. Journal of Alzheimers Disease, 26, 81–104.
Loef, M., von Stillfried, N., et al. (2012). Zinc diet and Alzheimer’s disease: a systematic review. Nutritional Neuroscience, 15(5), 2–12.
Loef, M., & Walach, H. (2012a). Copper and iron in Alzheimer’s disease: a systematic review and its dietary implications. British Journal of Nutrition, 107, 7–19.
Loef, M., & Walach, H. (2012b). Fatty acids and dementia: systematic review and meta-analyses. BMC Complementary and Alternative Medicine, 12(Suppl. 1), P318.
Loef, M., & Walach, H. (2012c). Fruit, vegetables and prevention of Alzheimer’s disease: a systematic review of cohort studies. Journal of Nutr Health Aging, 16(7), 626–630.
Loef, M. & Walach, H. (2012d). Midlife obesity and dementia: meta-analysis and adjusted forecast of dementia prevalence in the US and China. Obesity. doi: 10.1002/oby.20037.
Loef, M. and H. Walach (2012e). The effects of physical activity on the risk of dementia: a meta-analysis. In prep.
Loef, M., & Walach, H. (2012f). The combined effects of healthy lifestyle behaviors on all cause mortality: A systematic review and meta-analysis. Preventive Medicine, 55, 163–170.
Luchsinger, J. A., & Mayeux, R. (2004). Dietary factors and Alzheimer’s disease. The Lancet Neurology, 3(10), 579–587.
Luengo-Fernandez, R., Leal, J., et al. (2011). Cost of dementia in the pre-enlargement countries of the European Union. Journal of Alzheimers Disease, 27, 187–196.
Mangialasche, F., Kivipelto, M., et al. (2012). Dementia prevention: current epidemiological evidence and future perspective. Alzheimer’s Research & Therapy, 4(1), 6.
Mangialasche, F., Solomon, A., et al. (2011). Alzheimer’s disease: clinical trials and drug development. Lancet Neurology, 9, 702–716.
Marks, J., Porte, D., et al. (1990). Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology, 127(6), 3234–3236.
Martin, B., Mattson, M. P., et al. (2006). Caloric restriction and intermittent fasting: two potential diets for successful brain aging. Ageing Research Reviews, 5(3), 332–353.
Mason, M. F., Norton, M. I., et al. (2007). Wandering minds: the default network and stimulus-independent thought. Science, 315, 393–395.
McMahon, J. A., Green, T. J., et al. (2006). A controlled trial of homocysteine lowering and cognitive performance. New England Journal of Medicine, 354, 2764–2772.
Metzinger, T. (2006). Der Begriff einer “Bewusstseinskultur. e-Journal Philosophie der Psychologie (Jan).
Middleton, L. E., & Yaffe, K. (2010). Targets for the prevention of dementia. Journal of Alzheimer’s Disease, 20(3), 915–924.
Moffett, J. R., Ives, J. A., et al. (2009). Fatty acids and lipids in neurobiology: a brief overview. In R. R. Watson (Ed.), Fatty Acids in Health Promotion and Disease Causation (pp. 517–543). Urbana: AOCS Press.
Morgan, D. (2011). Immunotherapy for Alzheimer’s disease. Journal of Internal Medicine, 269(1), 54–63.
Morris, M. C., Evans, D. A., et al. (2003). Dietary fats and the risk of incident Alzheimer disease. Archives of Neurology, 60(2), 194–200.
Mössner, R., Mikova, O., et al. (2007). Consensus paper of the WFSBP task force on biological markers: biological markers in depression. World Journal of Biological Psychiatry, 8(3), 141–174.
Mulder, C., Schoonenboom, N. S. M., et al. (2005). The transmethylation cycle in the brain of Alzheimer patients. Neuroscience Letters, 386, 69–71.
Mutter, J., Curth, A., et al. (2010). Does inorganic mercury play a role in Alzheimer’s disease? A systematic review and an integrated molecular mechanism. Journal of Alzheimer’s Disease, 22, 357–374.
Neumann, K., Rojo, L., et al. (2008). Insulin resistance and Alzheimer’s disease: molecular links and clinical implications. Current Alzheimer Research, 5, 438–447.
Nyakas, C., Granic, I., et al. (2011). The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid b-42 with memantine. Behavioural Brain Research, 221, 594–603.
Orgogozo, J. M., Dartigues, J. F., et al. (1997). Wine consumption and demntia in the elderly: a prospective community study in the Bordeaux area. Revue de Neurologie (Paris), 153, 185–192.
Ornish, D. (2009). Mostly plants. American Journal of Cardiology. doi:10.1016/j.amjcard.2009.05.031.
Ornish, D., Scherwitz, L. W., et al. (1998). Intensive lifestyle changes for reversal of coronary heart disease. Journal of the American Medical Association, 280, 2001–2007.
Ornish, D., Weidner, G., et al. (2005). Intensive lifestyle changes may affect progression of prostate cancer. Journal of Urology, 174, 1065–1070.
Ott, U., Hölzel, B. K., et al. (2011). Brain structure and meditation: how spiritual practice shapes the brain. In H. Walach, S. Schmidt, & W. B. Jonas (Eds.), Neuroscience, consciousness and spritiuality (pp. 119–128). Dordrecht: Springer.
Oulhaj, A., Refsum, H., et al. (2009). Homocysteine as a predictor of cognitive decline in Alzheimer’s disease. International Journal of Geriatric Psychiatry, 25, 82–90.
Pagnoni, G., & Cekic, M. (2007). Age effects on gray matter volume and attentional perfomance in Zen meditation. Neurobiology of Aging, 28, 1623–1627.
Pagnoni, G., Cekic, M., et al. (2008). “Thinking about not-thinking”: Neural correlates of conceptual processing during Zen meditation. PLoS ONE, 3(9), e3083.
Penston, J. (2003). Fiction and fantasy in medical research: the large-scale randomised trial. London: The London Press.
Peters, R., Poulter, R., et al. (2008). Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatrics, 8(1), 36.
Pincus, D., & Metten, A. (2010). Nonlinear dynamics in biopsychosocial resilience. Nonlinear Dynamics, Psychology, and Life Sciences, 14, 353–380.
Pütz, P. (2008). Hypercortisolemic disorders. In: Hellhammer DH, Hellhammer J (eds) Stress: The Brain-Body Connection. Basel, Karger: 39-59.
Raichle, M. E., Marcus, E., et al. (2001). A default mode of brain funtion. Proceedings of the National Academy of Science USA, 98, 676–682.
Roberson, E. D., & Mucke, L. (2006). 100 years and counting: Prospects for defeating Alzheimer’s disease. Science, 314, 781–784.
Roll, S., Nocon, M. et al. (2010). Reduction of common cold symptoms by encapsulated juice powder concentrate of fruits and vegetables: a randomised, double-blind, placebo-controlled trial. British Journal of Nutrition. doi:10.1017/S000711451000317X: 1–5.
Rusanen, M., Kivipelto, M., et al. (2011). Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Archives of Internal Medicine, 171(4), 333–339.
Saczynski, J. S., Pfeifer, L. A., et al. (2006). The effect of social engagement on incident Dementia. American Journal of Epidemiology, 163(5), 433–440.
Scarmeas, N., Stern, Y., et al. (2009). Mediterranean diet and mild cognitive impairment. Archives of Neurology, 66(2), 216–225.
Schliebs, R., & Arendt, T. (2011). The cholinergic system in aging and neuronal degeneration. Behavioural Brain Research, 221, 555–563.
Schmitz, G., & Ecker, J. (2008). The opposing effects of n-3 and n-6 fatty acids. Progress in Lipid Research, 47(2), 147–155.
Sedlmeier, P., Eberth, J., et al. (2012). The psychological effects of meditation: a meta-analysis. Psychological Bulletin, 138(6), 1139–1171.
Shaw, K., Gennat, H., et al. (2006). Exercise for overweight or obesity. Cochrane Database of Systematic Reviews, 18(4), CD003817.
Siervo, M., Arnold, R., et al. (2011). Intentional weight loss in overweight and obese individuals and cognitive function: a systematic review and meta-analysis. Obesity Reviews, 12, 968–983.
Simopoulos, A. (2006). Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Food Technology, 60, 502–507.
Simopoulos, A. P. (1991). Omega-3 fatty acids in health and disease and in growth and development. The American Journal of Clinical Nutrition, 54(3), 438–463.
Simopoulos, A. P. (2011). Evolutionary aspects of diet: the Omega-6/Omega-3 ratio and the brain. Molecular Neurobiology, 29, 29.
Simopoulos, A. P., Norman, H. A., et al. (1992). Common purslane: a source of omega-3 fatty acids and antioxidants. Journal of the American College of Nutrition, 11(4), 374–382.
Sinha, R., Cross, A. J., et al. (2009). Meat intake and mortality: a prospective study of over half a million people. Archives of Internal Medicine, 169, 562–571.
Smallwood, J., & Schooler, J. W. (2006). The restless mind. Psychological Bulletin, 132, 946–958.
Snowdon, D. A. (1997). Aging and Alzheimer’s disease: lessons from the nun study. The Gerontologist, 37(2), 150–156.
Sontag, E., Nunbhakdi-Craig, V., et al. (2007). Protein phosphatase 2A mathyltransferase links homocysteine metabolis with tau and amyloid precursor protein regulation. Journal of Neuroscience, 27, 2751–2759.
Tabet, N., Birks, J. et al. (2008). Vitamin E for Alzheimer’s disease. Cochrane Database of Systematic Reviews (4):CD002854.
Teipel, S. J., Flatz, W. H., et al. (2005). Measurement of basal forebrain atrophy in Alzheimer’s disease using MRI. Brain, 128, 2626–2644.
Thomas, D. E., Elliott, E. J., et al. (2006). Exercise for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews, 3(3), CD002968.
Thompson, P. D., Buchner, D., et al. (2003). Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(8), e42–e49.
Trialist-Collaboration, H.-L. (2005). Dose dependent effects of folic acid on blood concentration of homocysteine: a meta-analysis of the randomized trials. American Journal of Clinical Nutrition, 82, 806–812.
van Dam, F., & van Gool, W. A. (2009). Hyperhomocysteinemia and Alzheimer’s disease: a systematic review. Archives of Gerontology and Geriatrics, 48, 425–430.
van Praag, H. M., de Kloet, R., et al. (2004). Stress, the brain, and depression. Cambridge: Cambridge University Press.
Warburton, D. E. R., Nicol, C. W., et al. (2006). Health benefits of physical activity: the evidence. Canadian Medical Association Journal, 174(6), 801–809.
Wang, Y. C., McPherson, K., et al. (2011). Health and economic burden of the projected obesity trends in the USA and the UK. Lancet, 378(9793), 815–825.
Whalley, L. J., Dick, F. D., et al. (2006). A life-course approach to the aetiology of late-onset dementias. The Lancet Neurology, 5(1), 87–96.
WHO. (2011). Global recommendations on physical activity for health. Retrieved from http://www.who.int/dietphysicalactivity/pa/en/index.html. Accessed 02 Aug 2011.
Wisdom, N. M., Callahan, J. L., et al. (2009). The effects of apolipoprotein E on non-impaired cognitive functioniong: a meta-analysis. Neurobiology of Aging, 32, 63–74.
Witte, A. V., Fobker, M., et al. (2009). Caloric restriction improves memory in elderly humans. Proceedings of the National Academy of Sciences of the United States of America, 106(4), 1255–1260.
Woodward, M. (2007). Dementia risk reduction: the evidence. Alzheimer’s Australia Paper 13.
Zatta, P., Drago, D., et al. (2009). Alzheimer’s disease, metal ions and metal homeostatic therapy. Trends in Pharmacological Sciences, 30(7), 346–355.
Acknowledgments
This work is supported by the Samueli Institute’s Brain, Mind and Healing Program, whose European operations HW is coordinating. ML has been supported by the Samueli Institute and the Hans Gottschalk-Stiftung.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Highlights
Highlights
-
Alzheimer’s Disease, and indeed dementias, are complex diseases with no single causal mechanism that might serve as a therapeutic target. They start much earlier in life before any clinical sign are visible.
-
This makes lifestyle, behavioral, as well as environmental factors potential multiple causes and possible access routes to public health measures, prevention, and perhaps also treatment at early stages.
-
Among the most important factors are the avoidance of neurotoxins such as aluminum, mercury, lead; the provision with essential nutrients such as selenium, antioxidants, and a good balance of omega-3 to omega-6 essential fatty acids of 1:4 to 1:1; reduction in calorie intake; exercise; a culture of consciousness, such as meditation and active stress reduction techniques; participatory social structures.
-
Important public health measures could be redistributing research efforts into studying how lifestyle, as an expression of lived individuality, could be molded through education and coaching to become more wholesome, and how such lifestyle decisions might impact on future prevalence of disease. Public education measures should provide the necessary information.
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Walach, H., Loef, M. (2013). Alzheimer’s Dementia and Lifestyle: Towards a Primary Prevention. In: Hall, P. (eds) Social Neuroscience and Public Health. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6852-3_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6852-3_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6851-6
Online ISBN: 978-1-4614-6852-3
eBook Packages: MedicineMedicine (R0)